P16877 AF NFT

Multidrug resistance protein 4 (Fragment)

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifz23ddpwk4t35ldhdc7otkeubpo7vtad6q73lvp2w3wppfi5jl2i/metadata.json
IPFS of structure file: 
bafybeidsbhmfynlmlu2yiuhhpta5qai2zx5wcegkarfucgboipk27t3qza/AF-P16877-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xb3c0C983Fc44934AC589D7131C08a72544EBB92E
First NFT owner address (bech32): 
genesis1k0qvnqlugjf543vf6uf3cz98y4zwhwfw5hvdqx
Current NFT ID #227940 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
227940
Accession (UniProt):
P16877
Name::
Multidrug resistance protein 4 (Fragment)
Experimental Method:
Predicted structure
Sequence source:
ENTAMOEBA HISTOLYTICA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P16877 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P16877|MDR4_ENTHI Multidrug resistance protein 4 (Fragment) OS=Entamoeba histolytica OX=5759 GN=MDR4 PE=3 SV=1 SGCGKSTSVQLIERFYDPTHGDVLLDGHNIRFEYSFLRSQIGMVGQEPVLFAESVMDNIRRGVPKGVEVSNEQIYAAAKMANAHDFISAMPEGYNTMVGDRGAQISGGQKQRI